6-Bromopyrido[2,3-d]pyrimidin-4-amine

Catalog No. :
ACQSEL731
CAS No. :
1121633-45-1
Molecular Formula :
C7H5BrN4
Molecular Weight :
225.05

IUPAC Name:6-bromopyrido[2,3-d]pyrimidin-4-amine

6-Bromopyrido[2,3-d]pyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$131.00Login to see priceInquiryInquiry
100mg98%$188.00Login to see priceInquiryInquiry
250mg98%$260.00Login to see priceInquiryInquiry
1g98%$626.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromopyrido[2,3-d]pyrimidin-4-amine
IUPAC Name6-bromopyrido[2,3-d]pyrimidin-4-amine
MDL No.MFCD11875768
Molecular FormulaC7H5BrN4
Molecular Weight225.05
SMILESNC1=C(C=C(Br)C=N2)C2=NC=N1
InChI KeyRQXUDXAAXGXEEU-UHFFFAOYSA-N
Synonym6-Bromo-pyrido[2,3-d]pyrimidin-4-ylamine;Pyrido[2,3-d]pyrimidin-4-amine, 6-bromo-
CAS No.1121633-45-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQSEL731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJECI571 route compound structure diagram
    ACJECI5711215787-31-7 In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACQSEL731 route product structure diagram
    ACQSEL7311121633-45-1
Inquiry

2. ACQSEL731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. ACJECI571 route compound structure diagram
    ACJECI5711215787-31-7 In Stock
  4. Plus
  5. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  6. Then
  7. ACQSEL731 route product structure diagram
    ACQSEL7311121633-45-1
Inquiry

Comments (0)